Indeed, BBB disruptions are a key feature of AD, bringing about increased BBB permeability leading to CNS microbleeding and perivascular infiltration of neurotoxic blood-derived products, cellular infiltration and degeneration of pericytes and ECs, as well as impaired GLUT-1 and P-gp function, which negatively impact glucose homeostasis and Aβ clearance (reviewed in [235,236]). The gene discussed is SLC2A1; the disease is Alzheimer disease.